Daron Evans has bought stock on 11 days since Apr 2018

Daron Evans (age 52 as of September 2025) is the Chief Financial Officer at Rezolute, Inc. (Nasdaq: RZLT), appointed on January 23, 2024.( He brings over 15 years of experience in financial operations, investor relations, and business development in public and private life science companies.(

Evans holds a B.S. in Chemical Engineering from Rice University, an M.S. in Biomedical Engineering from the University of Texas at Arlington/UT Southwestern joint program, and an MBA from Duke University's Fuqua School of Business.( His career highlights include serving as Chief Executive Officer of AlloRock, Inc. (cardiometabolic biotech), Specialty Renal Products, Inc. (dialysis devices), and Nephros, Inc. (medical devices), as well as CFO of Nile Therapeutics, Inc.( Since 2015, he has been Managing Director of PoC Capital, LLC, focusing on public life sciences investments.( As of recent data, he owns approximately 512,900 shares of RZLT stock.(

Written by Perplexity from public sources.